Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,624 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
Sato S, Fujimoto M, Hasegawa M, Takehara K. Sato S, et al. Among authors: hasegawa m. Arthritis Rheum. 2004 Jun;50(6):1918-27. doi: 10.1002/art.20274. Arthritis Rheum. 2004. PMID: 15188368
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1997 Feb;24(2):328-32. J Rheumatol. 1997. PMID: 9034992
Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis.
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1997 Apr;24(4):663-5. J Rheumatol. 1997. PMID: 9101498
Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Hasegawa M, et al. J Rheumatol. 1998 Feb;25(2):308-13. J Rheumatol. 1998. PMID: 9489824
OBJECTIVE: To determine whether serum interleukin 6 (IL-6), oncostatin M (OSM), soluble IL-6 receptor (sIL-6R), and soluble gp130 (sgp130) levels in patients with systemic sclerosis (SSc) are elevated and whether they are correlated with the clinical or serological feature …
OBJECTIVE: To determine whether serum interleukin 6 (IL-6), oncostatin M (OSM), soluble IL-6 receptor (sIL-6R), and soluble gp130 (sg …
IL-13 production by peripheral blood mononuclear cells from patients with atopic dermatitis.
Takamatsu Y, Hasegawa M, Sato S, Takehara K. Takamatsu Y, et al. Among authors: hasegawa m. Dermatology. 1998;196(4):377-81. doi: 10.1159/000017928. Dermatology. 1998. PMID: 9669111
Antigen specificity of antihistone antibodies in systemic sclerosis.
Hasegawa M, Sato S, Kikuchi K, Takehara K. Hasegawa M, et al. Ann Rheum Dis. 1998 Aug;57(8):470-5. doi: 10.1136/ard.57.8.470. Ann Rheum Dis. 1998. PMID: 9797552 Free PMC article.
Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S, Hasegawa M, Nagaoka T, Takamatsu Y, Yazawa N, Ihn H, Kikuchi K, Takehara K. Sato S, et al. Among authors: hasegawa m. J Rheumatol. 1998 Nov;25(11):2135-9. J Rheumatol. 1998. PMID: 9818655
Systemic sclerosis revealing T-cell lymphoma.
Hasegawa M, Sato S, Sakai H, Ohashi T, Takehara K. Hasegawa M, et al. Dermatology. 1999;198(1):75-8. doi: 10.1159/000018070. Dermatology. 1999. PMID: 10026408
Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity.
Shimada Y, Sato S, Hasegawa M, Tedder TF, Takehara K. Shimada Y, et al. Among authors: hasegawa m. J Allergy Clin Immunol. 1999 Jul;104(1):163-8. doi: 10.1016/s0091-6749(99)70128-4. J Allergy Clin Immunol. 1999. PMID: 10400854
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis.
Hasegawa M, Sato S, Takehara K. Hasegawa M, et al. Clin Exp Immunol. 1999 Jul;117(1):159-65. doi: 10.1046/j.1365-2249.1999.00929.x. Clin Exp Immunol. 1999. PMID: 10403930 Free PMC article.
3,624 results
Jump to page
Feedback